Skip to main content
. Author manuscript; available in PMC: 2014 Jul 23.
Published in final edited form as: Circulation. 2013 Jul 23;128(4):10.1161/CIRCULATIONAHA.113.001840. doi: 10.1161/CIRCULATIONAHA.113.001840

Table.

Future directions and potential research in the investigation of obesity and AF.

Domain Directions and potential research questions
Epidemiology and phenotype modeling Diversity of adiposity phenotypes (DEXA, skin caliper measurement, obesity subphenotypes, CT imaging)
Trajectories of obesity exposure and “obesity-years”
Childhood obesity and early-age weight with longitudinal (i.e. multi-decade) AF risk
Effect modification and augmented risk from comorbidities
Cohort studies and secondary data analysis Weight loss, i.e. bariatric cohorts, and AF risk assessment
Effect of weight loss on epicardial adiposity and AF risk
Atrial and cardiovascular remodeling Community- and population-based studies of atrial remodeling and simultaneous biomarker assessment (i.e. adipokines, inflammatory markers)
Regression (reverse remodeling) following bariatric intervention or weight loss
Regression (reverse remodeling) with risk factor amelioration (e.g. OSA treatment)
Genetics and genomics Gene-environment interaction relating obesity-years, genetic expression, and AF risk
Relation of microRNA expression in AF to obesity-years

AF indicates atrial fibrillation; DEXA, dual-energy X-ray absorptiometry; CT, computerized tomography; OSA, obstructive sleep apnea.

HHS Vulnerability Disclosure